About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
19th Conference of the International Society of Geriatric Oncology
www.siogconference.org
Breast
Hematologic Oncology
Lung
Business
General Oncology
Palliative Care
Gastrointestinal
Genitourinary
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
83 y/o Male with Metastatic Castration-Sensitive Prostate Cancer: Both Endocrine Therapy (Abiraterone / Enzalutamide) and Cabazitaxel May Be Considered in Elderly
By
19th Conference of the International Society of Geriatric Oncology
FEATURING
Antonella Brunello
By
19th Conference of the International Society of Geriatric Oncology
FEATURING
Antonella Brunello
255 views
December 30, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:46
AstraZeneca Oncology
First-line Maintenance Treatment Option in Patients With HRD-Positiv…
Feat.
S. Lewin
Featured Video
20:09
AstraZeneca Oncology
Management Strategies for Anemia in First-line Maintenance Therapy f…
Feat.
D. Czel,
C. Arn
Genitourinary
02:59
19th Conference of the International Society of Geriatric Oncology
Increase in Incidence of Septicemia in mCRPC Might Be Associated w/ …
Feat.
N. Nikita
30:37
19th Conference of the International Society of Geriatric Oncology
83 y/o Male with Metastatic Castration-Sensitive Prostate Cancer: Bo…
Feat.
A. Brunello
